Spring Research Update Meeting 2025
Our 2025 Spring Research Update Meeting will take place at BMA House, home of the British Medical Association, in Tavistock Square, London on 24 March where we invite guests to an inspiring agenda of some of the most up to date news of our funded...
Learn more
The Mike Tindall Celebrity Golf Classic 2019
We are very grateful to Mike and Zara Tindall for generously supporting this wonderful day of golf and entertainment again in aid of Cure Parkinson’s
The Bristol GDNF results
Today – 27th February, 2019 – the long-awaited results of the Phase II GDNF clinical trial were published. GDNF (or glial cell line-derived neurotrophic factor) is a protein that our bodies naturally produce to nurture and support cells. Extensive preclinical research suggested that this protein was particularly supportive of dopamine neurons – a group […]
Exciting Exenatide Exosomes
Recent analysis of blood samples collected during the Phase II clinical trial of Exenatide in Parkinson’s has uncovered a very interesting finding that could have major implications for not only Parkinson’s, but for many different neurological conditions. Exenatide is a treatment that helps to control glucose levels in people with diabetes. More recently, however, […]
Tom Isaacs award winners 2018 – Prof. Bas Bloem & Dr Simon Stott
Cure Parkinson’s and Van Andel Research Institute have announced Dr. Simon Stott (above left) and Professor Bastiaan Bloem (above right) as joint recipients of this year’s ‘Tom Isaacs Award’. The comprehensive nominations for both candidates made choosing between them very difficult – therefore it was…
Tom Isaacs Award winner 2017 – Prof. Tom Foltynie
Cure Parkinson’s and Van Andel Institute (VAI) are proud to announce Professor Tom Foltynie, Consultant Neurologist and Researcher at University College, London, as the inaugural winner of the Tom Isaacs Award. The award was presented today at the annual Grand Challenges in Parkinson’s conference and Rallying to the…